Mycoplasma pneumoniae nucleε&£®ic acid detection kit (P​§≠®CR-fluorescent probe m♣×σ÷ethod)

Mycoplasma pneumoni→§ae (M. Pneumonia, MP) is the pathogen of human myπ↓coplasma pneumonia. Theδ☆ pathological changes of mycoplasm≈πa pneumonia are mainl×δ'÷y interstitial pneumonia, sometimes complicat¥♥♠₹ed by bronchial pneumonia, which is called≠♣×∏ primary atypical pneumonia. Worldwide, $→&™multiple studies have shown t←®₹hat the annual MP infection rate is ♣¥§9.6% to 66.7%, the infection rat<§e during non-epidemic period is 10×λπ% to 20%, and MP acc±★ounts for more than 30% of pedλ÷✘×iatric pneumonia during epidemic per₽γ$iod. There are approximately 156 Ωγ×million children with pneumonia each year, ♥<←of which 151 million children ♠‌©with pneumonia occur in ≤σ♦developing countries and are the leading cau← ×∏se of death for childr≤λ↓♥en under 5 years of age, accouα♠↕βnting for 19% of the total num↔¥ber of deaths. It is also the m<​ain cause of death among adults, especially aπ$mong the elderly.
Mainly infected by droplets, the incubation perioγ≤∞d is 2 to 3 weeks, and the incidence is the high‌Ω↕est among adolescents. The clinical sy ♠£mptoms are mild, or e←§ven asymptomatic at all, and if t•π$÷here are only general respiratory  •symptoms such as headache, sore throat, f♠ α↕ever, cough, etc., but there ha•¶♦ve been individual dea≠€'th reports. It can happen all year round, but £↓mostly in autumn and winte∑↓✔r.